Cydar is pleased to announce that its endovascular 3D surgical guidance software has gained FDA 510(k) clearance. “This FDA clearance is a crucial step in delivering our technology globally”, said Cydar co-founder and CEO Tom Carrell.
We are pleased to announce that Cydar Endovascular has a CE mark. This is fantastic news and we would like to thank everyone involved. To have Cydar Endovascular 3D overlays in your hospital, please get in touch with us: email@example.com